Dr Marcelo Cypel’s groundbreaking clinical trial is delivering chemotherapy directly to cancer tissue – sparing the rest of the body from toxic side effects.
1 min. read
Dr Marcelo Cypel, Canadian Cancer Society-funded researcher
Chemotherapy is an effective treatment option for many people facing cancer. However, its toxicity comes with many painful side effects.
But what if chemotherapy could be delivered directly to tumour tissue – sparing the rest of the body?
With your support, Dr Marcelo Cypel and his team are doing just that. They are conducting a clinical trial where people with cancer that has spread to the lungs will receive chemotherapy directly to their lung tissue – sparing the rest of the body from its toxic effects. Building on previous CCS-funded work that showed this method’s safety, Dr Cypel and his team are now expanding the trial to more people to evaluate whether the chemotherapy is effective for their tumours.
If successful, this project could lead to better treatment for people with cancer that has spread to the lungs – improving their chances of survival and quality of life.
“Thank you for your generous support,” says Dr Cypel. “You continue to propel important research, fueling discoveries that have life-saving impact and potential.”
But what if chemotherapy could be delivered directly to tumour tissue – sparing the rest of the body?
With your support, Dr Marcelo Cypel and his team are doing just that. They are conducting a clinical trial where people with cancer that has spread to the lungs will receive chemotherapy directly to their lung tissue – sparing the rest of the body from its toxic effects. Building on previous CCS-funded work that showed this method’s safety, Dr Cypel and his team are now expanding the trial to more people to evaluate whether the chemotherapy is effective for their tumours.
If successful, this project could lead to better treatment for people with cancer that has spread to the lungs – improving their chances of survival and quality of life.
“Thank you for your generous support,” says Dr Cypel. “You continue to propel important research, fueling discoveries that have life-saving impact and potential.”